Добавил:

Sekretar kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.

Вуз:

Ростовский Государственный Медицинский Университет

Предмет:

Медицина общая

Файл:

Книга_5491_Библиотеки_им_академика_М_И_Перельмана

.pdf

Скачиваний:

Добавлен:

13.10.2026

Размер:

3 Мб

Скачать

☆

<<< < Предыдущая 1 2 3 4 5 6 7 89 / 369 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 > Следующая >>>

central nervous system, including the enhancement of GABAergic

neurotransmission.

 Euphoria and Mood Alteration: Betameprodine can induce feelings of

euphoria, well-being, and pleasure, commonly referred to as a "high." This

effect is mediated by the activation of mu-opioid receptors in the brain's

reward pathway, leading to the release of dopamine and other

neurotransmitters associated with pleasure and reward.

 Physical Dependence and Tolerance: Prolonged use of Betameprodine can

lead to the development of physical dependence, where the body becomes

adapted to the presence of the drug and experiences withdrawal

symptoms upon discontinuation. Additionally, tolerance may develop,

requiring higher doses of the drug to achieve the same level of analgesia.

 Gastrointestinal Effects: Betameprodine can cause constipation by

decreasing gastrointestinal motility through the activation of opioid

receptors in the enteric nervous system. This effect is due to the inhibition

of acetylcholine release and subsequent smooth muscle relaxation in the

gastrointestinal tract.

 Cardiovascular Effects: Betameprodine can cause peripheral vasodilation

and orthostatic hypotension, leading to a decrease in blood pressure.

These effects are mediated by the release of histamine and the inhibition

of sympathetic nervous system activity.

Analysis:

Analysis of Betameprodine can be performed using various physical and

chemical methods to determine its identity, purity, and quality. Here are the details

of the analysis methods:

Physical Method:

 Appearance and Color: Betameprodine can be visually inspected for its

physical appearance and color, which should match the expected

characteristics of a white crystalline powder or crystals.

 Melting Point: The melting point of Betameprodine can be determined

using a melting point apparatus. The observed melting point can be

compared to the known literature value to assess the purity of the

compound.

 Solubility: Solubility testing involves dissolving Betameprodine in various

solvents (e.g., water, ethanol) to determine its solubility characteristics,

which can provide information about its purity and physical properties.

https://t.me/med1917

Chemical Method:

 Chromatographic Techniques: High-performance liquid chromatography

(HPLC) or gas chromatography (GC) can be used for the separation and

quantification of Betameprodine in a sample. These techniques are

sensitive and can provide information about the compound's purity and

concentration.

 Spectroscopic Techniques: Spectroscopic methods such as infrared (IR)

spectroscopy and nuclear magnetic resonance (NMR) spectroscopy can be

used to analyze the molecular structure of Betameprodine and identify

functional groups present in the compound.

 Mass Spectrometry (MS): Mass spectrometry can be used to determine the

molecular weight and structural information of Betameprodine by

ionizing the compound and measuring the mass-to-charge ratio of its ions.

 Titration Methods: Titration methods involve the reaction of

Betameprodine with a known reagent of known concentration to

determine its concentration in the sample. Acid-base titration or

oxidation-reduction titration methods can be used for Betameprodine

analysis.

https://t.me/med1917

BETAMETHADOL

IUPAC name: 1-(4-Methoxyphenyl)-4-(N-methyl-N-propionylamino)piperidine

Molecular structure:

A) Physical Properties:

 Scientific Name: Betamethadol.

 Appearance: Betamethadol typically appears as a white crystalline powder

or as small crystals.

 Color: White.

 Odour: Typically odorless.

 Taste: Not commonly reported.

 Melting Point: [Melting point information not readily available].

 Boiling Point: [Boiling point information not readily available].

Solubility:

 Water: Sparingly soluble.

 Alcohol: Soluble.

B] Chemical Properties:

 Chemical Formula: C21H29NO2.

 Chemical Classification: Betamethadol is a synthetic opioid analgesic.

 Functional Group: Contains an amine functional group (-NH2).

 pH: Not commonly reported.

https://t.me/med1917

How it is Made? From Where it is Obtained?

Betamethadol is synthesized in laboratory settings through a multistep

chemical synthesis process. The specific synthetic route and chemical precursors

used may vary depending on the manufacturer and synthesis method employed. It

is obtained through licensed pharmaceutical manufacturing facilities and is not

naturally occurring.

Route of Administration: Betamethadol is primarily administered orally,

although other routes may also be utilized depending on the formulation and

clinical circumstances:

 Oral Administration: Betamethadol is commonly administered orally in

the form of tablets or solutions. This route is convenient and allows for

systemic absorption through the gastrointestinal tract.

 Parenteral Administration: In certain clinical situations, Betamethadol

may be administered parenterally, either intramuscularly (IM) or

intravenously (IV), for more rapid onset of action or when oral

administration is not feasible.

 Transdermal Administration: While less common, Betamethadol may also

be administered transdermally through specialized patches that deliver

the drug through the skin for systemic absorption.

 Rectal Administration: In some cases, Betamethadol may be administered

rectally in the form of suppositories, particularly in palliative care settings

or for patients who cannot tolerate oral medications.

Pharmacological Actions: Betamethadol is a synthetic opioid analgesic that acts

primarily on opioid receptors in the central nervous system. Here are the key

pharmacological actions of Betamethadol:

 Analgesia: Betamethadol provides potent analgesic effects by binding to

mu-opioid receptors in the brain and spinal cord. Activation of these

receptors inhibits the transmission of pain signals and alters pain

perception, resulting in pain relief. Betamethadol is effective in the

management of moderate to severe pain, including both acute and chronic

pain conditions.

 Respiratory Depression: Like other opioids, Betamethadol can cause

respiratory depression by suppressing the activity of respiratory centers

in the brainstem. This effect leads to a decrease in respiratory rate and

depth, which may result in respiratory insufficiency or respiratory arrest,

particularly at higher doses. Respiratory depression is one of the most

significant adverse effects associated with opioid analgesics, including

Betamethadol.

https://t.me/med1917

 Sedation: Betamethadol has sedative properties, leading to drowsiness,

lethargy, and a general feeling of calmness or relaxation. This effect is

mediated through the modulation of neurotransmitter activity in the

central nervous system, including the enhancement of GABAergic

neurotransmission. Sedation is a common side effect of opioid analgesics

and may contribute to their therapeutic effects, particularly in managing

pain-related anxiety and discomfort.

 Euphoria and Mood Alteration: Betamethadol can induce feelings of

euphoria, well-being, and pleasure, commonly referred to as a "high." This

effect is mediated by the activation of mu-opioid receptors in the brain's

reward pathway, leading to the release of dopamine and other

neurotransmitters associated with pleasure and reward. Euphoria and

mood alteration are common side effects of opioid analgesics and may

contribute to their potential for misuse and addiction.

 Physical Dependence and Tolerance: Prolonged use of Betamethadol can

lead to the development of physical dependence, where the body becomes

adapted to the presence of the drug and experiences withdrawal

symptoms upon discontinuation. Additionally, tolerance may develop,

requiring higher doses of the drug to achieve the same level of analgesia.

Physical dependence and tolerance are common phenomena associated

with chronic opioid therapy and require careful management to prevent

withdrawal symptoms and maintain effective pain control.

 Gastrointestinal Effects: Betamethadol can cause constipation by

decreasing gastrointestinal motility through the activation of opioid

receptors in the enteric nervous system. This effect is due to the inhibition

of acetylcholine release and subsequent smooth muscle relaxation in the

gastrointestinal tract. Constipation is one of the most common and

bothersome side effects of opioid analgesics and may require

pharmacological or non-pharmacological interventions for management.

 Cardiovascular Effects: Betamethadol can cause peripheral vasodilation

and orthostatic hypotension, leading to a decrease in blood pressure.

These effects are mediated by the release of histamine and the inhibition

of sympathetic nervous system activity. Orthostatic hypotension,

characterized by a sudden drop in blood pressure upon standing, can lead

to dizziness, lightheadedness, and falls, particularly in elderly patients or

those with pre-existing cardiovascular conditions.

Analysis:

Analysis of Betamethadol involves various physical and chemical methods

to assess its identity, purity, and quality. Here are some common analysis

techniques:

https://t.me/med1917

Physical Methods:

 Appearance and Color: Visual inspection of Betamethadol for its physical

appearance and color, typically as a white crystalline powder or crystals.

 Melting Point: Determination of the melting point using a melting point

apparatus to assess the purity of the compound.

 Solubility: Solubility testing involves determining the solubility of

Betamethadol in various solvents, such as water and alcohol, which can

provide information about its physical properties.

Chemical Methods:

 Chromatographic Techniques: High-performance liquid chromatography

(HPLC) or gas chromatography (GC) can be used for separation and

quantification of Betamethadol in a sample, providing information about

its purity and concentration.

 Spectroscopic Techniques: Spectroscopic methods such as infrared (IR)

spectroscopy and nuclear magnetic resonance (NMR) spectroscopy can be

used to analyze the molecular structure of Betamethadol and identify

functional groups present in the compound.

 Mass Spectrometry (MS): Mass spectrometry can be used to determine the

molecular weight and structural information of Betamethadol by ionizing

the compound and measuring the mass-to-charge ratio of its ions.

 Titration Methods: Titration methods involve the reaction of

Betamethadol with a known reagent of known concentration to determine

its concentration in the sample. Acid-base titration or oxidation-reduction

titration methods can be used for Betamethadol analysis.

https://t.me/med1917

BETAPRODINE

IUPAC name: (1,3Dimethyl4phenylpiperidin4yl) propanoate

Scientific name: Betaprodine

Molecular Structure:

Physical properties:

 Appearance: Typically in powder form

 Color: Can vary, often white or off-white

 Odor: Usually odorless

 Taste: Typically bitter

 Melting Point (M.P): Varies depending on the form and purity

 Boiling Point (B.P): 338.4ºC at 760mmHg

 Solubility: Soluble in water and alcohol

 Molar Mass: Varies depending on the specific compound

Chemical Properties:

 Chemical formula: C16H23NO2

 Chemical classification: Synthetic opioid

 Functional groups: Contains functional groups typical of opioids

 pH: Not readily available

Source and synthesis: Betaprodine is usually synthesized in a laboratory setting.

Route of Administration: It's typically administered orally, intravenously, or

intramuscularly.

Pharmacological Action: As an opioid, it acts on the opioid receptors in the body,

primarily μopioid receptors, to produce analgesic effects.

https://t.me/med1917

Analysis:

Physical Methods:

1. Melting Point Determination

 Purpose: To verify purity and identity.

 Method: Use a melting point apparatus to determine the temperature at

which betaprodine transitions from solid to liquid.

2. Solubility Testing

 Purpose: To understand solubility in various solvents.

 Method: Measure the amount of betaprodine that dissolves in solvents like

water, ethanol, and chloroform at room temperature.

3. Optical Rotation

 Purpose: To determine optical activity.

 Method: Use a polarimeter to measure the angle of rotation of polarized

light passing through a solution of betaprodine.

4. Crystallography

 Purpose: To determine the crystal structure.

 Method: Use X-ray crystallography to analyze the

 3D arrangement of atoms in betaprodine crystals.

5. Particle Size Analysis

 Purpose: To determine the size distribution of particles in powdered form.

 Method: Use techniques like laser diffraction or microscopy.

Chemical Methods:

1. Spectroscopy

NMR (Nuclear Magnetic Resonance) Spectroscopy

 Purpose: To determine the molecular structure and purity.

 Method: Analyze the magnetic properties of hydrogen (¹H NMR) or carbon

(¹³C NMR) nuclei in the betaprodine molecule.

IR (Infrared) Spectroscopy

 Purpose: To identify functional groups.

 Method: Measure the absorption of IR radiation by the betaprodine

sample, producing a spectrum that indicates specific bonds.

UV-Vis (Ultraviolet-Visible) Spectroscopy

https://t.me/med1917

 Purpose: To analyze the electronic transitions in the molecule.

 Method: Measure the absorption of UV or visible light by the betaprodine

solution.

2. Chromatography

HPLC (High-Performance Liquid Chromatography)

 Purpose: To separate, identify, and quantify components.

 Method: Pass a solution of betaprodine through a column packed with a

solid adsorbent, analyzing the time it takes for different components to

elute.

GC (Gas Chromatography)

 Purpose: To analyze volatile components.

 Method: Vaporize the betaprodine sample and pass it through a column,

with separation based on volatility and interaction with the column

material.

3. Mass Spectrometry (MS)

 Purpose: To determine molecular weight and structure.

 Method: Ionize betaprodine molecules and measure the mass-to-charge

ratio of the ions, providing information on molecular fragments.

4. Elemental Analysis

 Purpose: To determine the percentage composition of carbon, hydrogen,

nitrogen, and oxygen.

 Method: Burn the sample in an elemental analyzer and measure the

resulting gases.

5. Titration

 Purpose: To determine purity and concentration.

 Method: React a known quantity of betaprodine with a titrant of known

concentration, observing the endpoint to calculate the amount of

substance.

6. Thin Layer Chromatography (TLC)

 Purpose: To quickly assess purity and identify components.

 Method: Spot a small amount of betaprodine on a TLC plate, develop the

plate in a solvent system, and analyze the pattern of separated spots.

https://t.me/med1917

BEZITRAMIDE

IUPAC name:

4[4(2oxo3propanoylbenzimidazol1yl)piperidin1yl]2,2diphenylbutanenitrile

Scientific name: Bezitramide

Molecular Structure:

Physical Properties:

 Appearance: Solid or powder form.

 Color: White to offwhite.

 Odor: Typically odorless.

 Taste: Typically bitter.

 Melting point (M.P): 145149 °C Varies depending on the form and purity.

 Solubility: Soluble in water and alcohol to some extent.

 Molar Mass: Not readily available without specific

Chemical properties:

 Molecular Formula: C31H32N4O2

 Chemical classification: Opioid analgesic.

Functional groups: Contains amine and ester functional groups.

Source & Synthesis: Bezitramide can be synthesized through chemical reactions

involving precursor compounds in a laboratory setting. The specific synthesis

route is typically proprietary information owned by pharmaceutical companies.

Route of Administration: Bezitramide is primarily administered orally.

Pharmacological Action: It acts as an opioid analgesic, similar to other opioids, by

binding to opioid receptors in the central nervous system to alleviate pain.

https://t.me/med1917

<<< < Предыдущая 1 2 3 4 5 6 7 89 / 369 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 > Следующая >>>

Соседние файлы в папке Библиотека им академика М.И. Перельмана

#
12.10.20263 Мб0Книга_5487_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20263 Мб0Книга_5488_Библиотеки_им_академика_М_И_Перельмана.mobi
#
12.10.20263 Мб0Книга_5489_Библиотеки_им_академика_М_И_Перельмана.pdf
#
29.08.202684 Мб0Книга_549_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20263 Мб0Книга_5490_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5491_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5492_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5493_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5494_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20263 Мб0Книга_5495_Библиотеки_им_академика_М_И_Перельмана.pdf
#
13.10.20262 Мб0Книга_5497_Библиотеки_им_академика_М_И_Перельмана.pdf